Učitavanje...
Repositionnement de la chlorpromazine dans le traitement du COVID-19 : étude reCoVery
OBJECTIVES: The ongoing COVID-19 pandemic comprises a total of more than 2,350,000 cases and 160,000 deaths. The interest in anti-coronavirus drug development has been limited so far and effective methods to prevent or treat coronavirus infections in humans are still lacking. Urgent action is needed...
Spremljeno u:
| Izdano u: | Encephale |
|---|---|
| Glavni autori: | , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
L'Encéphale, Paris.
2020
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7188634/ https://ncbi.nlm.nih.gov/pubmed/32387014 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.encep.2020.04.010 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|